General Information of the Compound
| Compound ID |
CP0040177
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-((2E,6E)-3,7,11-Trimethyl-dodeca-2,6,10-trienylsulfanyl)-benzoic acid
Show/Hide
|
||||||||||||||||||
| Synonyms |
FTS
162520-00-5
2-(((2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl)sulfanyl)benzoic acid
2-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienylthio)benzoic acid
2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulfanylbenzoic acid
2-[[(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl]thio]benzoic Acid
AK186909
Benzoic acid, 2-(((2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl)thio)-
CHEMBL23293
FTS (oral, cancer), Concordia
FTS (oral, cancer), Concordia/Ono
FTS, Thyreos
Farnesyl Thiosalicylic Acid
Farnesylthiosalicyclic acid
Farnesylthiosalicyclic acid (oral, cancer), Concordia
Farnesylthiosalicylic acid
KD032
MZH0OM550M
Ras antagonists, Thyreos
Ras-inhibitors (cancer), Concordia
S-Farnesylthiosalicylic acid
S-trans
Salirasib
Th-101
Trans-farnesylthiosalicylicacid
UNII-MZH0OM550M
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H30O2S
|
||||||||||||||||||
| Molecular Weight |
358.547
|
||||||||||||||||||
| Canonical SMILES |
CC(C)=CCC\C(C)=C\CC\C(C)=C\CSc1ccccc1C(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H30O2S/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-25-21-14-6-5-13-20(21)22(23)24/h5-6,9,11,13-15H,7-8,10,12,16H2,1-4H3,(H,23,24)/b18-11+,19-15+
Show/Hide
|
||||||||||||||||||
| InChIKey |
WUILNKCFCLNXOK-CFBAGHHKSA-N
|
||||||||||||||||||
| CAS |
162520-00-5
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound